12:00 AM
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cobicistat regulatory update

Gilead submitted an NDA to FDA for cobicistat as a boosting agent for HIV treatment with protease inhibitors. The inhibitor...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >